Monosol Rx Genpar, L.p. - Net Worth and Insider Trading
Monosol Rx Genpar, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Monosol Rx Genpar, L.p. owns 1 companies in total, including Aquestive Therapeutics Inc (AQST) .
Click here to see the complete history of Monosol Rx Genpar, L.p.’s form 4 insider trades.
Insider Ownership Summary of Monosol Rx Genpar, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AQST | Aquestive Therapeutics Inc | 2018-07-24 | 10 percent owner |
Monosol Rx Genpar, L.p. Trading Performance
Monosol Rx Genpar, L.p. Ownership Network
Monosol Rx Genpar, L.p. Owned Company Details
What does Aquestive Therapeutics Inc do?
Who are the key executives at Aquestive Therapeutics Inc?
Monosol Rx Genpar, L.p. is the 10 percent owner of Aquestive Therapeutics Inc. Other key executives at Aquestive Therapeutics Inc include director & Chief Innovation/Tech Officer Alexander Mark Schobel , Chief Medical Officer Carl N Kraus , and SVP & Research & Development Stephen Wargacki .
Aquestive Therapeutics Inc (AQST) Insider Trades Summary
Over the past 18 months, Monosol Rx Genpar, L.p. made no insider transaction in Aquestive Therapeutics Inc (AQST). Other recent insider transactions involving Aquestive Therapeutics Inc (AQST) include a net sale of 75,000 shares made by Alexander Mark Schobel ,
In summary, during the past 3 months, insiders sold 0 shares of Aquestive Therapeutics Inc (AQST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 75,000 shares of Aquestive Therapeutics Inc (AQST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 75,000 shares.
Aquestive Therapeutics Inc (AQST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aquestive Therapeutics Inc Insider Transactions
Monosol Rx Genpar, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Monosol Rx Genpar, L.p.. You might contact Monosol Rx Genpar, L.p. via mailing address: C/o Bratton Capital Management, 201 Main Street, Suite 1900, Fort Worth Tx 76102.